In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 200 for your search:
Trial Type:  Prevention, Genetics
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Prevention, Treatment
Status: Active
Age: 30 and over
Sponsor: Other
Protocol IDs: 940110, NCT00155389

2.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 12 to 15
Sponsor: Pharmaceutical / Industry
Protocol IDs: 106636, 2007-001731-55, NCT00534638

3.

Phase: Phase IV
Type: Prevention
Status: Approved-not yet active
Age: 13 to 15
Sponsor: Other
Protocol IDs: 37207, NCT01021904

4.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 15 to 25
Sponsor: Pharmaceutical / Industry
Protocol IDs: 109823, 2013-003429-28, NCT01031069

5.

Phase: Phase IV
Type: Behavioral study, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-0585-AE, Protocol# in Pfizer: GA30517W, NCT00937508

6.

Phase: Phase IV
Type: Natural history/Epidemiology, Prevention
Status: Active
Age: 70 and over
Sponsor: Other
Protocol IDs: 1U01AG029824-01A2, NCT01038583

7.

Phase: Phase IV
Type: Behavioral study, Prevention
Status: Active
Age: 16 to 45
Sponsor: Other
Protocol IDs: P50DA016511, NCT00664755

8.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 11 to 17
Sponsor: Other
Protocol IDs: GardasilMerckGomez-Lobo, NCT01101750

9.

Phase: Phase IV
Type: Behavioral study, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 1U01CA 159533-01, NCT01289275

10.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 55 and over
Sponsor: NCI, Other
Protocol IDs: ROI10-352, R01CA138627, NCT01296672

11.

Phase: Phase IV
Type: Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10-0933, NCT01229319

12.

Phase: Phase IV
Type: Prevention, Treatment
Status: Active
Age: 15 to 45
Sponsor: Other
Protocol IDs: 4-Chaudhuri, NCT01630954

13.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 40-to 60
Sponsor: Other
Protocol IDs: 2008BAI57B04, NCT01698164

14.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 18 to 26
Sponsor: Other
Protocol IDs: CIHR-MOP-125949, IIS #38265, NCT01824537

15.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 64
Sponsor: Other
Protocol IDs: 12-36, NCT02047994

16.

Phase: Phase IV
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2014-0207, NCT02162849

17.

Phase: Phase III, Phase II
Type: Behavioral study, Prevention
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: NIDA-16427-5, R01-16427-5, DPMC, NCT00132821

18.

Phase: Phase III, Phase II
Type: Behavioral study, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 15597, 5R01AA019720-02, NCT01182766

19.

Phase: Phase III, Phase II
Type: Prevention
Status: Approved-not yet active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 0727-11-HMO, NCT01813240

20.

Phase: Phase III, Phase II
Type: Prevention
Status: Active
Age: 20 to 80
Sponsor: Other
Protocol IDs: CF13197, NCT01964001

21.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: S10251, NCT01426490

22.

Phase: Phase III, Phase II
Type: Prevention
Status: Active
Age: 50 to 80
Sponsor: Other
Protocol IDs: SQ2011SF12RJ, SQ2011SF12-20121010, NCT02066688

23.

Phase: Phase III, Phase II
Type: Prevention
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2014BAI09B05, NCT02143505

24.

Phase: Phase III, Phase II
Type: Prevention
Status: Approved-not yet active
Age: 18 to 65
Sponsor: Other
Protocol IDs: RJ2014BH, NCT02226185

25.

Phase: Phase III
Type: Prevention
Status: Active
Age: 40 to 80
Sponsor: Other
Protocol IDs: BE-2-27, NCT00780754
1     
New Search